We are excited to announce that the WHO recently awarded a contract to researchers and clinicians from the University of Sydney (MBI Fungisphere Node) and Australian & New Zealand Mycoses Interest Group (ANZMIG) to develop a priority pathogen list for fungi. This list follows the success of the 2017 WHO priority pathogen list for bacteria, which has already had a major impact on focusing global R&D on the most pressing bacterial threats.
Our group is extremely diverse, bringing together expertise in mycology, healthcare decision making, One Health, and patient safety. Fungal pathogens are often ignored, and we have huge gaps in knowledge on how to diagnose, treat, and monitor trends, including the emergence of anti-fungal resistance. We are looking forward to working with WHO to identify the biggest gaps, and shine some much needed light the topic’
MBI extends its congratulations to the whole team.